BIOMAT Database Logo BIOMAT Database Logo

Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. 1988

L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Laboratoire de Microbiologie Médicale, Université Pierre et Marie Curie, Paris, France.

TEM-7, a novel TEM-type beta-lactamase (pI 5.41) encoded on a plasmid of approximately 85 kilobases, was found in a clinical isolate of Citrobacter freundii. Strains containing this enzyme exhibited decreased susceptibility to ceftazidime (64-fold) and aztreonam (16-fold) but not to other third-generation cephalosporins. Addition of a beta-lactamase inhibitor--clavulanic acid, sulbactam, or YTR 830--restored normal susceptibility to associated compounds such as ampicillin, piperacillin, ceftazidime, and aztreonam. DNA-DNA hybridization of an intragenic probe of TEM-1 occurred with a 19-kilobase EcoRI fragment of the plasmid encoding TEM-7. A TEM-2 derivative, TEM-201, with characteristics similar to those of TEM-7 was selected spontaneously in the presence of ceftazidime in vitro.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002954 Citrobacter A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
September 1989, Antimicrobial agents and chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.
March 2002, Antimicrobial agents and chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
June 1998, Antimicrobial agents and chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
TEM-E1: a novel beta-lactamase conferring resistance to ceftazidime.
May 1989, FEMS microbiology letters,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Monoclonal antibodies to TEM-1 plasmid-mediated beta-lactamase.
November 1987, Antimicrobial agents and chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Mutants of the TEM-1 beta-lactamase conferring resistance to ceftazidime.
August 1989, The Journal of antimicrobial chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
September 1993, Antimicrobial agents and chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Plasmid-mediated ceftazidime resistance.
February 1989, The Journal of antimicrobial chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Plasmid-mediated ceftazidime resistance.
July 1989, The Journal of antimicrobial chemotherapy,
L Gutmann, and M D Kitzis, and D Billot-Klein, and F Goldstein, and G Tran Van Nhieu, and T Lu, and J Carlet, and E Collatz, and R Williamson
Recognition and resistance in TEM beta-lactamase.
July 2003, Biochemistry,
Copied contents to your clipboard!